Similar articles

• [A case of antimony resistant kala-azar cured with amphotericin B].

  Chen SB, Yang CM, Zhang CJ. Chen SB, et al. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007 Jun;25(3):inside front page. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007. PMID: 18038767 Chinese. No abstract available.
• Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

  Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D. Lira R, et al. J Infect Dis. 1999 Aug;180(2):564-7. doi: 10.1086/314896. J Infect Dis. 1999. PMID: 10395884
• Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.

  Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK. Das VN, et al. Natl Med J India. 2005 May-Jun;18(3):131-3. Natl Med J India. 2005. PMID: 16130613
• Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.

  Sangraula H, Sharma KK, Rijal S, Dwivedi S, Koirala S. Sangraula H, et al. J Assoc Physicians India. 2003 Jul;51:686-90. J Assoc Physicians India. 2003. PMID: 14621038 Review.
• Engima of therapeutic failure in visceral leishmaniasis.

  Arya SC. Arya SC. J Assoc Physicians India. 1993 Mar;41(3):155-8. J Assoc Physicians India. 1993. PMID: 8226600 Review. No abstract available.